(Q40353124)

19 September 2017

Chemical blockage of the proteasome inhibitory function of bortezomib: impact on tumor cell death (English)

1 reference

19 September 2017

1 reference

Yolanda Fernández

1

1 reference

19 September 2017

Thomas P Miller

2

1 reference

19 September 2017

Christophe Denoyelle

3

1 reference

19 September 2017

Jose A Esteban

4

1 reference

19 September 2017

Wen-Hua Tang

5

1 reference

19 September 2017

Audrey L Bengston

6

1 reference

19 September 2017

María S Soengas

7

1 reference

19 September 2017

language of work or name

English

0 references

publication date

8 November 2005

1 reference

Journal of Biological Chemistry

19 September 2017

1 reference

19 September 2017

281

1 reference

19 September 2017

1107-1118

1 reference

19 September 2017

2

1 reference

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

19 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Aberrant ubiquitin-mediated proteolysis of cell cycle regulatory proteins and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Endoproteolytic activity of the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Deadly encounter: ubiquitin meets apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

The proteasome: a suitable antineoplastic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Proteasome inhibition as a novel therapeutic target in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

The development of proteasome inhibitors as anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

The compressed feature matrix?a fast method for feature based substructure search

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

The role of proteasome inhibitors in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Clinical update: proteasome inhibitors in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Approval summary for bortezomib for injection in the treatment of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

A phase II study of bortezomib in the treatment of metastatic malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Bortezomib, a newly approved proteasome inhibitor for the treatment of multiple myeloma: nursing implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Loss of endothelium-derived nitric oxide in rabbit aorta by oxidant stress: restoration by superoxide dismutase mimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Cell permeable ROS scavengers, Tiron and Tempol, rescue PC12 cell death caused by pyrogallol or hypoxia/reoxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

The combinatorial synthesis and chemical and biological evaluation of a 1,4-benzodiazepine library

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Human xenografts, human skin and skin reconstructs for studies in melanoma development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Interaction of hHR23 with S5a. The ubiquitin-like domain of hHR23 mediates interaction with S5a subunit of 26 S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Ubiquitin recognition by the DNA repair protein hHR23a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Human melanoma progression in skin reconstructs : biological significance of bFGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Flow cytometry of apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Molecular mechanisms of N-acetylcysteine actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Synergistic effect of histone deacetylase inhibitors FK228 and m-carboxycinnamic acid bis-hydroxamide with proteasome inhibitors PSI and PS-341 against gastrointestinal adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

N-acetylcysteine modifies cis-dichlorodiammineplatinum-induced effects in bladder cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Effects of platinum and palladium ions on the production and reactivity of neutrophil-derived reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Tacrolimus decreases in vitro oxidative phosphorylation of mitochondria from rat forebrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Vitamin E and genome stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Therapeutics against mitochondrial oxidative stress in animal models of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

The superoxide dismutase mimetic MnTBAP prevents Fas-induced acute liver failure in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

A phase I and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (bortezomib, velcade), in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Images in clinical Medicine. Bortezomib-induced skin lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Mechanisms of cancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Timeline: Chemotherapy and the war on cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Proteasomes and their kin: proteases in the machine age

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomib

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Hydrogen peroxide mediates FK506-induced cytotoxicity in renal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Insulin generates free radicals by an NAD(P)H, phosphatidylinositol 3'-kinase-dependent mechanism in human skin fibroblasts ex vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Decreased modulation by lipopolysaccharide of aortic smooth muscle contractility in streptozotocin-induced hyperglycemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Primary granule release from human neutrophils is potentiated by soluble fibrinogen through a mechanism depending on multiple intracellular signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Anesthetic Preconditioning Improves Adenosine Triphosphate Synthesis and Reduces Reactive Oxygen Species Formation in Mitochondria after Ischemia by a Redox Dependent Mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Anion exchanger as a reaction/separation medium-absorptiometric determination of trace amounts of boron in waters by on-line complexation with chromotropic acid presorbed on the anion-exchange column

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511607200

21 January 2018

Identifiers

DOI

10.1074/JBC.M511607200

1 reference

19 September 2017

1 reference